Influence of the sympathetic nervous system on aortic compliance. 1980

C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan

1. Aortic compliance and plasma catecholamine levels were determined in 26 essential hypertensive patients: 14 < 45 years (group 1) and 12 > 45 years (group 2). 2. Aortic rigidity, the reciprocal of aortic compliance, was calculated by the ratio of pulse pressure to stroke volume. Pulse pressure was derived by arterial pressure measured in the ascending aorta. Stroke volume was obtained by dye dilution. 3. A significant correlation (r = 0.60) was found between aortic rigidity and plasma noradrenaline in group 2. In this group both aortic rigidity and plasma noradrenaline levels were consistently higher than in group 1. 4. In 15 patients (seven of group 1 and eight of group 2) aortic rigidity was again measured after acute phentolamine (five patients) and labetalol (ten patients) administration. 5. Aortic rigidity was reduced significantly after both alpha-adrenoreceptor blockade alone and combined alpha- and beta-adrenoreceptor blockade. A highly significant correlation was found between aortic rigidity reduction and pretreatment noradrenaline levels (r = 0.77). 6. Aortic compliance is influenced, at least in part, by sympathetic nervous system activity. Drugs which block the peripheral effects of catecholamines may improve aortic compliance and consequently the control of systolic hypertension in selected cases.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D003187 Compliance Distensibility measure of a chamber such as the lungs (LUNG COMPLIANCE) or bladder. Compliance is expressed as a change in volume per unit change in pressure.
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
June 2006, Annals of the New York Academy of Sciences,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
January 1941, The Journal of physiology,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
July 1978, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
September 1995, Acta physiologica Scandinavica,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
March 1976, Japanese heart journal,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
August 1987, Lancet (London, England),
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
May 1977, Biulleten' eksperimental'noi biologii i meditsiny,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
January 1956, Archiv fur Ohren-, Nasen- und Kehlkopfheilkunde,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
July 1998, Acta physiologica Scandinavica,
C L Alicandri, and R Fariello, and E Agabiti-Rosei, and G Romanelli, and G Muiesan
January 1973, Life sciences. Pt. 1: Physiology and pharmacology,
Copied contents to your clipboard!